Activation studies of the β-carbonic anhydrases from


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 29 3 2020
pubmed: 29 3 2020
medline: 16 12 2020
Statut: ppublish

Résumé

The β-carbonic anhydrase (CA, EC 4.2.1.1) from the genome of the opportunistic pathogen

Identifiants

pubmed: 32216477
doi: 10.1080/14756366.2020.1743284
pmc: PMC7170391
doi:

Substances chimiques

Amines 0
Amino Acids 0
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

824-830

Références

Mar Drugs. 2019 Apr 22;17(4):
pubmed: 31013612
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
Bioorg Chem. 2018 Oct;80:94-98
pubmed: 29894892
Bioorg Med Chem. 2019 Apr 15;27(8):1588-1594
pubmed: 30846402
Curr Pharm Des. 2008;14(7):708-15
pubmed: 18336317
Bioorg Med Chem Lett. 2016 Mar 1;26(5):1381-5
pubmed: 26856923
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1701-4
pubmed: 20129782
Bioorg Med Chem Lett. 2014 Sep 15;24(18):4389-4396
pubmed: 25168745
Bioorg Med Chem Lett. 2014 Jan 1;24(1):275-9
pubmed: 24314394
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1305-1312
pubmed: 29072105
Expert Opin Drug Discov. 2017 Jan;12(1):61-88
pubmed: 27783541
J Enzyme Inhib Med Chem. 2018 Dec;33(1):680-685
pubmed: 29536765
Metabolites. 2017 Nov 11;7(4):
pubmed: 29137134
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6194-8
pubmed: 18930395
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1506-1510
pubmed: 31431090
J Enzyme Inhib Med Chem. 2018 Dec;33(1):25-30
pubmed: 29098887
Bioorg Med Chem Lett. 2017 Jan 1;27(1):77-80
pubmed: 27881231
Bioorg Med Chem. 2014 Jan 1;22(1):531-7
pubmed: 24268544
J Med Chem. 2011 Mar 24;54(6):1896-902
pubmed: 21361354
Bioorg Chem. 2018 Apr;77:1-5
pubmed: 29316507
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1178-1185
pubmed: 31282230
J Inorg Biochem. 2012 Jun;111:117-29
pubmed: 22192857
Expert Opin Ther Targets. 2015 Apr;19(4):551-63
pubmed: 25495426
Neuropharmacology. 2017 May 15;118:148-156
pubmed: 28286213
Metabolites. 2019 Jul 18;9(7):
pubmed: 31323880
Biochemistry. 1997 Aug 26;36(34):10384-92
pubmed: 9265618
J Enzyme Inhib Med Chem. 2018 Dec;33(1):227-233
pubmed: 29231751
Expert Opin Drug Discov. 2019 Nov;14(11):1175-1197
pubmed: 31436118
Bioorg Med Chem. 2008 Apr 1;16(7):3530-6
pubmed: 18294854
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Int J Mol Sci. 2019 May 17;20(10):
pubmed: 31108925
Future Med Chem. 2018 Mar 1;10(5):561-573
pubmed: 29478330
Expert Opin Ther Pat. 2018 Oct;28(10):713-721
pubmed: 30175635
Expert Opin Ther Targets. 2015;19(12):1689-704
pubmed: 26235676
ACS Cent Sci. 2019 Feb 27;5(2):308-318
pubmed: 30834319
J Enzyme Inhib Med Chem. 2018 Dec;33(1):151-157
pubmed: 29199489
Mar Drugs. 2016 Jun 03;14(6):
pubmed: 27271641
Bioorg Chem. 2019 Feb;82:117-122
pubmed: 30312866
Angew Chem Int Ed Engl. 2014 Apr 14;53(16):4231-5
pubmed: 24623670
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15184-9
pubmed: 10611359
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
ISME J. 2019 Aug;13(8):2094-2106
pubmed: 31024153
Behav Pharmacol. 2018 Sep;29(6):482-492
pubmed: 29570113
Int J Mol Sci. 2018 May 24;19(6):
pubmed: 29795045
J Mol Biol. 2009 Jan 30;385(4):1207-20
pubmed: 19071134
J Enzyme Inhib Med Chem. 2018 Dec;33(1):945-950
pubmed: 29747543
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4107-12
pubmed: 17540561
J Med Chem. 2012 Apr 12;55(7):3513-20
pubmed: 22424239
Mol Neurobiol. 2018 Sep;55(9):7431-7437
pubmed: 29423818
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1385-9
pubmed: 25765908
J Enzyme Inhib Med Chem. 2015 Apr;30(2):325-32
pubmed: 24766661
J Enzyme Inhib Med Chem. 2016;31(3):345-60
pubmed: 26619898
Bioorg Med Chem. 2017 Jun 15;25(12):3093-3097
pubmed: 28400084
Bioorg Chem. 2018 Aug;78:406-410
pubmed: 29689418
J Enzyme Inhib Med Chem. 2016 Oct;31(5):689-94
pubmed: 26118417

Auteurs

Andrea Angeli (A)

Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino (Florence), Italy.

Sonia Del Prete (SD)

Department of Biology, Agriculture and Food Sciences, Institute of Biosciences and Bioresources, CNR, Napoli, Italy.

Cynthia Ghobril (C)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Julien Hitce (J)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Cécile Clavaud (C)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Xavier Marrat (X)

L'Oréal Research and Innovation, Aulnay-sous-Bois, France.

William A Donald (WA)

School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia.

Clemente Capasso (C)

Department of Biology, Agriculture and Food Sciences, Institute of Biosciences and Bioresources, CNR, Napoli, Italy.

Claudiu T Supuran (CT)

Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino (Florence), Italy.
School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

Aminoacid functionalised magnetite nanoparticles Fe

Spoială Angela, Motelica Ludmila, Ilie Cornelia-Ioana et al.
1.00
Magnetite Nanoparticles Tryptophan Biocompatible Materials Microbial Sensitivity Tests Humans
Intrinsically Disordered Proteins Protein Conformation Nuclear Magnetic Resonance, Biomolecular Amino Acids Computational Biology

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines
Humans Male Female Coronary Artery Disease Aged

Classifications MeSH